Stocks and Investing
Stocks and Investing
Wed, March 21, 2012
[ 07:41 AM ] - WOPRAI
[ 07:41 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 06:30 AM ] - Market Wire
[ 06:22 AM ] - WOPRAI
[ 06:21 AM ] - WOPRAI
[ 06:21 AM ] - WOPRAI
[ 06:21 AM ] - WOPRAI
[ 06:20 AM ] - WOPRAI
[ 06:20 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:15 AM ] - Market Wire
[ 05:00 AM ] - Market Wire
[ 03:20 AM ] - WOPRAI
[ 03:20 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matt Miksic Maintained (ABT) at Hold with Increased Target to $60 on, Mar 21st, 2012
Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $56 to $60 on, Mar 21st, 2012.
Matt has made no other calls on ABT in the last 4 months.
There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matt
- Brittany Henderson of "Deutsche Bank" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Monday, March 19th, 2012